Skip to main content
Top
Published in: Inflammation 5/2019

01-10-2019 | ORIGINAL ARTICLE

Anti-histaminic Effects of Resveratrol and Silymarin on Human Gingival Fibroblasts

Authors: Amir Farzanegan, Mohammad Shokuhian, Soudeh Jafari, Fatemeh Sadeghi Shirazi, Minoo Shahidi

Published in: Inflammation | Issue 5/2019

Login to get access

Abstract

Periodontitis as a chronic inflammatory disease leads to the destruction of the supportive tissues of affected teeth. Crosstalk between periodontitis and the host immune system plays a crucial role in the pathogenesis of this disease. Since polyphenol components such as silymarin and resveratrol have anti-bacterial and anti-inflammatory effects on periodontal tissues, the purpose of this study was to investigate the anti-histaminic effects of silymarin and resveratrol on human gingival fibroblasts (HGFs). HGFs were treated with a concentration of silymarin or resveratrol (100 μg/ml) and a combination of these two polyphenols (50/100 or 100/200 μg/ml silymarin/resveratrol). The effect of silymarin and resveratrol on cell viability was assessed by MTT assay. Also, HGFs were treated with silymarin and/or resveratrol and were stimulated by histamine. The levels of interleukin-6 (IL-6), interleukin-8 (IL-8), tumor necrosis factor alpha (TNF-α), and tissue plasminogen activator 1 (TPA-1) were assessed by enzyme-linked immunosorbent assay (ELISA). After treatment with silymarin, the viability of fibroblast cells significantly increased, whereas treatment with resveratrol and combinations of these flavonoids (silymarin 50 μg/ml and resveratrol 100 μg/ml) did not have any significant effect on cell viability after 24 h. Treatment with 100/200 μg/ml silymarin/resveratrol significantly decreased the cell viability after 48 h. Resveratrol inhibited histamine-induced IL-6 secretion by HGFs significantly, whereas silymarin showed significant effect on TNF-α. A blend of silymarin and resveratrol displayed more valuable results. In conclusion, combination of resveratrol and silymarin could significantly inhibit inflammatory effects of histamine on cultured HGFs by reduction of IL-6, IL-8, TPA-1, and TNF-α.
Literature
2.
go back to reference Shahidi, M., F. Vaziri, A. Haerian, A. Farzanegan, S. Jafari, R. Sharifi, and F.S. Shirazi. 2017. Proliferative and anti-inflammatory effects of resveratrol and silymarin on human gingival fibroblasts: a view to the future. Journal of Dentistry (Tehran, Iran) 14 (4): 203. Shahidi, M., F. Vaziri, A. Haerian, A. Farzanegan, S. Jafari, R. Sharifi, and F.S. Shirazi. 2017. Proliferative and anti-inflammatory effects of resveratrol and silymarin on human gingival fibroblasts: a view to the future. Journal of Dentistry (Tehran, Iran) 14 (4): 203.
6.
go back to reference Toyman, U., G. Tüter, B. Kurtiş, E. Kıvrak, Ş. Bozkurt, A. Yücel, and M. Serdar. 2015. Evaluation of gingival crevicular fluid levels of tissue plasminogen activator, plasminogen activator inhibitor 2, matrix metalloproteinase-3 and interleukin 1-β in patients with different periodontal diseases. Journal of Periodontal Research 50 (1): 44–51. https://doi.org/10.1111/jre.12179.CrossRefPubMed Toyman, U., G. Tüter, B. Kurtiş, E. Kıvrak, Ş. Bozkurt, A. Yücel, and M. Serdar. 2015. Evaluation of gingival crevicular fluid levels of tissue plasminogen activator, plasminogen activator inhibitor 2, matrix metalloproteinase-3 and interleukin 1-β in patients with different periodontal diseases. Journal of Periodontal Research 50 (1): 44–51. https://​doi.​org/​10.​1111/​jre.​12179.CrossRefPubMed
8.
go back to reference Lin, L., and K. Hu. 2014. Tissue plasminogen activator and inflammation: from phenotype to signaling mechanisms. American journal of clinical and experimental immunology 3 (1): 30.PubMedPubMedCentral Lin, L., and K. Hu. 2014. Tissue plasminogen activator and inflammation: from phenotype to signaling mechanisms. American journal of clinical and experimental immunology 3 (1): 30.PubMedPubMedCentral
9.
go back to reference Venza, M., M. Visalli, M. Cucinotta, D. Cicciù, P. Passi, and D. Teti. 2006. Salivary histamine level as a predictor of periodontal disease in type 2 diabetic and non-diabetic subjects. Journal of Periodontology 77 (9): 1564–1571.CrossRefPubMed Venza, M., M. Visalli, M. Cucinotta, D. Cicciù, P. Passi, and D. Teti. 2006. Salivary histamine level as a predictor of periodontal disease in type 2 diabetic and non-diabetic subjects. Journal of Periodontology 77 (9): 1564–1571.CrossRefPubMed
11.
go back to reference Talreja, J., M.H. Kabir, M.B. Filla, D.J. Stechschulte, and K.N. Dileepan. 2004. Histamine induces Toll-like receptor 2 and 4 expression in endothelial cells and enhances sensitivity to Gram-positive and Gram-negative bacterial cell wall components. Immunology 113 (2): 224–233.CrossRefPubMedPubMedCentral Talreja, J., M.H. Kabir, M.B. Filla, D.J. Stechschulte, and K.N. Dileepan. 2004. Histamine induces Toll-like receptor 2 and 4 expression in endothelial cells and enhances sensitivity to Gram-positive and Gram-negative bacterial cell wall components. Immunology 113 (2): 224–233.CrossRefPubMedPubMedCentral
15.
17.
go back to reference Křen, V., and D. Walterova. 2005. Silybin and silymarin–new effects and applications. Biomed papers 149 (1): 29–41.CrossRef Křen, V., and D. Walterova. 2005. Silybin and silymarin–new effects and applications. Biomed papers 149 (1): 29–41.CrossRef
20.
go back to reference Hatamochi, A., H. Ueki, C. Mauch, and T. Krieg. 1991. Effect of histamine on collagen and collagen m-RNA production in human skin fibroblasts. Journal of Dermatological Science 2 (6): 407–412.CrossRefPubMed Hatamochi, A., H. Ueki, C. Mauch, and T. Krieg. 1991. Effect of histamine on collagen and collagen m-RNA production in human skin fibroblasts. Journal of Dermatological Science 2 (6): 407–412.CrossRefPubMed
23.
go back to reference Anarthe, R., A. Mani, and P. Marawar. 2013. Host modulatory therapy: a novel approach in the periodontal therapy. ISOR Journal of Pharmacy 3: 9–13. Anarthe, R., A. Mani, and P. Marawar. 2013. Host modulatory therapy: a novel approach in the periodontal therapy. ISOR Journal of Pharmacy 3: 9–13.
25.
go back to reference Gutiérrez-Venegas, G., S. Cruz-Arrieta, M. Villeda-Navarro, and J.A. Méndez-Mejía. 2011. Histamine promotes the expression of receptors TLR2 and TLR4 and amplifies sensitivity to lipopolysaccharide and lipoteichoic acid treatment in human gingival fibroblasts. Cell Biology International 35 (10): 1009–1017. https://doi.org/10.1042/CBI20100624.CrossRefPubMed Gutiérrez-Venegas, G., S. Cruz-Arrieta, M. Villeda-Navarro, and J.A. Méndez-Mejía. 2011. Histamine promotes the expression of receptors TLR2 and TLR4 and amplifies sensitivity to lipopolysaccharide and lipoteichoic acid treatment in human gingival fibroblasts. Cell Biology International 35 (10): 1009–1017. https://​doi.​org/​10.​1042/​CBI20100624.CrossRefPubMed
26.
go back to reference Tan, X., S. Essengue, J. Talreja, J. Reese, D.J. Stechschulte, and K.N. Dileepan. 2007. Histamine directly and synergistically with lipopolysaccharide stimulates cyclooxygenase-2 expression and prostaglandin I2 and E2 production in human coronary artery endothelial cells. The Journal of Immunology 179 (11): 7899–7906. https://doi.org/10.4049/jimmunol.179.11.7899.CrossRefPubMed Tan, X., S. Essengue, J. Talreja, J. Reese, D.J. Stechschulte, and K.N. Dileepan. 2007. Histamine directly and synergistically with lipopolysaccharide stimulates cyclooxygenase-2 expression and prostaglandin I2 and E2 production in human coronary artery endothelial cells. The Journal of Immunology 179 (11): 7899–7906. https://​doi.​org/​10.​4049/​jimmunol.​179.​11.​7899.CrossRefPubMed
28.
go back to reference Sheethal, H., H. Kn, T. Smitha, and K. Chauhan. 2018. Role of mast cells in inflammatory and reactive pathologies of pulp, periapical area and periodontium. Journal of oral and maxillofacial pathology: JOMFP 22 (1): 92–97.PubMed Sheethal, H., H. Kn, T. Smitha, and K. Chauhan. 2018. Role of mast cells in inflammatory and reactive pathologies of pulp, periapical area and periodontium. Journal of oral and maxillofacial pathology: JOMFP 22 (1): 92–97.PubMed
29.
go back to reference Rathod, S., A. Raj, and I. Wanikar. 2018. Quantitative analysis of mast cell count and density in chronic periodontal disease. Journal of Indian Society of Periodontology 22 (2): 107–111.CrossRefPubMedPubMedCentral Rathod, S., A. Raj, and I. Wanikar. 2018. Quantitative analysis of mast cell count and density in chronic periodontal disease. Journal of Indian Society of Periodontology 22 (2): 107–111.CrossRefPubMedPubMedCentral
32.
go back to reference Patil, R.H., R. Babu, M.N. Kumar, K.K. Kumar, S.M. Hegde, R. Nagesh, G.T. Ramesh, and S.C. Sharma. 2016. Anti-inflammatory effect of apigenin on LPS-induced pro-inflammatory mediators and AP-1 factors in human lung epithelial cells. Inflammation 39 (1): 138–147.CrossRefPubMed Patil, R.H., R. Babu, M.N. Kumar, K.K. Kumar, S.M. Hegde, R. Nagesh, G.T. Ramesh, and S.C. Sharma. 2016. Anti-inflammatory effect of apigenin on LPS-induced pro-inflammatory mediators and AP-1 factors in human lung epithelial cells. Inflammation 39 (1): 138–147.CrossRefPubMed
33.
go back to reference Evren, E., and E. Yurtcu. 2015. In vitro effects on biofilm viability and antibacterial and antiadherent activities of silymarin. Folia Microbiologica 60 (4): 351–356.CrossRefPubMed Evren, E., and E. Yurtcu. 2015. In vitro effects on biofilm viability and antibacterial and antiadherent activities of silymarin. Folia Microbiologica 60 (4): 351–356.CrossRefPubMed
34.
go back to reference Kohda, F., T. Koga, H. Uchi, K. Urabe, and M. Furue. 2002. Histamine-induced IL-6 and IL-8 production are differentially modulated by IFN-γ and IL-4 in human keratinocytes. Journal of Dermatological Science 28 (1): 34–41.CrossRefPubMed Kohda, F., T. Koga, H. Uchi, K. Urabe, and M. Furue. 2002. Histamine-induced IL-6 and IL-8 production are differentially modulated by IFN-γ and IL-4 in human keratinocytes. Journal of Dermatological Science 28 (1): 34–41.CrossRefPubMed
35.
go back to reference Wang, L., Q.-H. Huang, Y.-X. Li, Y.-F. Huang, J.-H. Xie, L.-Q. Xu, Y.-X. Dou, Z.-R. Su, H.-F. Zeng, and J.-N. Chen. 2018. Protective effects of silymarin on triptolide-induced acute hepatotoxicity in rats. Molecular Medicine Reports 17 (1): 789–800.PubMed Wang, L., Q.-H. Huang, Y.-X. Li, Y.-F. Huang, J.-H. Xie, L.-Q. Xu, Y.-X. Dou, Z.-R. Su, H.-F. Zeng, and J.-N. Chen. 2018. Protective effects of silymarin on triptolide-induced acute hepatotoxicity in rats. Molecular Medicine Reports 17 (1): 789–800.PubMed
36.
go back to reference Shirley, D., C. McHale, and G. Gomez. 2016. Resveratrol preferentially inhibits IgE-dependent PGD2 biosynthesis but enhances TNF production from human skin mast cells. Biochimica et Biophysica Acta (BBA) - General Subjects 1860 (4): 678–685.CrossRef Shirley, D., C. McHale, and G. Gomez. 2016. Resveratrol preferentially inhibits IgE-dependent PGD2 biosynthesis but enhances TNF production from human skin mast cells. Biochimica et Biophysica Acta (BBA) - General Subjects 1860 (4): 678–685.CrossRef
37.
go back to reference Mbimba, T., P. Awale, D. Bhatia, W.J. Geldenhuys, A.S. Darvesh, R.T. Carroll, and A. Bishayee. 2012. Alteration of hepatic proinflammatory cytokines is involved in the resveratrol-mediated chemoprevention of chemically-induced hepatocarcinogenesis. Current Pharmaceutical Biotechnology 13 (1): 229–234.CrossRefPubMed Mbimba, T., P. Awale, D. Bhatia, W.J. Geldenhuys, A.S. Darvesh, R.T. Carroll, and A. Bishayee. 2012. Alteration of hepatic proinflammatory cytokines is involved in the resveratrol-mediated chemoprevention of chemically-induced hepatocarcinogenesis. Current Pharmaceutical Biotechnology 13 (1): 229–234.CrossRefPubMed
Metadata
Title
Anti-histaminic Effects of Resveratrol and Silymarin on Human Gingival Fibroblasts
Authors
Amir Farzanegan
Mohammad Shokuhian
Soudeh Jafari
Fatemeh Sadeghi Shirazi
Minoo Shahidi
Publication date
01-10-2019
Publisher
Springer US
Published in
Inflammation / Issue 5/2019
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-019-01023-z

Other articles of this Issue 5/2019

Inflammation 5/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.